Reverse Transcriptase Inhibitors

Reverse Transcriptase Inhibitors (RTIs) are a type of antiviral medication used to treat HIV and AIDS. RTIs act by blocking the action of the reverse transcriptase enzyme, which is responsible for converting the HIV virus's genetic material (RNA) into DNA. This prevents the virus from replicating and infecting new host cells. RTIs are an important part of the medical regimen for treating HIV and AIDS, as they can prevent the spread of the virus and potentially provide long-term control of the disease. They are also used in a variety of research settings, where they are used to track the activity of HIV, determine the genetic sequence of HIV, and monitor the progress of treatment.

← Journal of Clinical Research In HIV AIDS And Prevention

Related Articles

6 article(s) found

A Rare Cause of Fever of Unknown Origin: Reverse Shapiro’s Syndrome

Full-text HTML Download PDF Download XML

Docking Studies of HIV-1 Reverse Transcriptase and HIV-1 Protease with Phytocompounds of Carissa Carandas L.

Full-text HTML Download PDF Download XML

Nucleoside and Nucleotide Reverse Transcriptase Inhibitors Induce Aging by Inhibiting Telomerase Function

Full-text HTML Download PDF Download XML

Stem Cell Differentiation Stage Factors (SCDSFs) Taken from Zebrafish Embryo during Organogenesis and their Role as Epigenetics Regulators able to Reverse Neurosensory Hearing Loss

Full-text HTML Download PDF Download XML

Cross-Reactivity between COX-2 Inhibitors in Patients with Cross-Reactive Hypersensitivity to NSAIDs

Full-text HTML Download PDF Download XML

Natural Polyphenols as Inhibitors for the Binding of Covid-19 S-RBD with ACE-2

Full-text HTML Download PDF Download XML